Številke

Bibliografija osebe. Seznam zajema vsa gradiva in ne le tista, kje je oseba mentor.

Doktorska dela (3)

1. Tina Roblek: Vloga kliničnega farmacevta pri obravnavi klinično pomembnih interakcij med zdravili pri bolnikih s srčnim popuščanjem
2. Nanča Čebron Lipovec: Metabolic profiles of patients with chronic obstructive pulmonary disease before and after rehabilitation
3. Daniel Omersa: Ocena epidemioloških značilnosti srčnega popuščanja v Sloveniji

Diplomska dela (3)

1. Petra Jančar: Analiza učinkovitosti klinične poti za zdravljenje z nizkomolekulskimi heparini v bolnišnici Golnik
2. Anja Nanut: Vpliv komorbidnosti in sočasnega zdravljenja z zdravili na urejenost antikoagulacijskega zdravljenja z varfarinom
3. Andreja Detiček: Vpliv bolnišnične obravnave na farmakoterapijo bolnikov s srčnim popuščanjem

Druga dela (26)

1. Tim Kambič, Vedran Hadžić, Mitja Lainščak: Hemodynamic response to high- and low-load resistance exercise in patients with coronary artery disease
2. Tim Kambič, Nejc Šarabon, Vedran Hadžić, Mitja Lainščak: Objectively measured physical activity in patients with coronary artery disease
3. Živa Lavriša, Hristo Hristov, Maša Hribar, Barbara Koroušić-Seljak, Matej Gregorič, Urška Blaznik, Katja Zaletel, Adrijana Oblak, Joško Osredkar, Anita Kušar, Katja Žmitek, Mitja Lainščak, Igor Pravst: Dietary iron intake and biomarkers of iron status in Slovenian population
4. Tim Kambič, Nejc Šarabon, Mitja Lainščak, Vedran Hadžić: Combined resistance training with aerobic training improves physical performance in patients with coronary artery disease
5. Katja Čvan Trobec, Iztok Grabnar, Jurij Trontelj, Mitja Lainščak, Mojca Kerec Kos: Population pharmacokinetics of ramipril in patients with chronic heart failure
6. Luka Hiti, Tijana Markovič, Mitja Lainščak, Jerneja Farkaš-Lainščak, Emil Pal, Irena Mlinarič-Raščan: The immunopathogenesis of a cytokine storm
7. Luka Varda, Robert Ekart, Mitja Lainščak, Uroš Maver, Sebastjan Bevc: Clinical properties and non-clinical testing of mineralocorticoid receptor antagonists in in vitro cell models
8. Gregor Verček, Tjaša Furlan, Dalibor Gavrić, Mitja Lainščak, Jerneja Farkaš-Lainščak, Irena Ograjenšek, Petra Došenović Bonča, Borut Jug: Statins for secondary prevention in women with atherosclerotic vascular disease
9. Borut Jug, Zlatko Fras, Tjaša Furlan, Marko Novaković, Jerneja Tasič, Mitja Lainščak, Jerneja Farkaš-Lainščak, Dalibor Gavrić, Irena Ograjenšek, Petra Došenović Bonča: Uptake and effectiveness of outpatient vs. residential cardiac rehabilitation after myocardial infarction
10. David Žižek, Marta Cvijić, Mitja Lainščak: Pharmacotherapy post-cardiac resynchronization therapy
11. Luka Petravić, Kaja Gril Rogina, Rok Miklič, Mitja Lainščak, Tinkara Langus, Anže Žnidaršič, Andreja Kukec, Matej Strnad: Strategic PAD positioning
12. Mitja Lainščak, Tina Zupanič, Daniel Omersa, Ivan Eržen, Jerneja Farkaš-Lainščak: Prevalence of cachexia and outcomes in patients with chronic diseases
13. Anja Kokalj Palandačić, Saša Ucman, Dragan Kovačić, Brigita Novak Šarotar, Mitja Lainščak: Anxiety in patients referred for elective coronary angiography
14. Mitja Lainščak, Gianluigi Savarese: Real-world heart failure registries
15. Stefan D. Anker, Mitja Lainščak: Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial
16. Mahir Karakas, Mitja Lainščak: Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial)
17. Luka Čavka, Alessandro Laviano, Mitja Lainščak: Frailty in cancer
18. Stephan Haehling, Mitja Lainščak: Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency
19. Stefan D. Anker, Mitja Lainščak: Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
20. Piotr Ponikowski, Mitja Lainščak, Stefan D. Anker: Hospitalization of symptomatic patients with heart failure and moderate to severe functional mitral regurgitation treated with MitraClip
21. Irena Šarc, Ramon C. J. Langen, Harry Reinier Gosker, Mitja Lainščak: Calprotectin and sarcopenia in COPD: biomarker, bystander or target?
22. Lars H. Lund, Mitja Lainščak: Heart failure in Europe
23. Tim Kambič, Tadej Debevec, Mitja Lainščak: Can intermittent hypoxic conditioning enhance the benefits of standard long COVID-19 rehabilitation?
24. Amr Abdin, Mitja Lainščak: European Society of Cardiology quality indicators update for the care and outcomes of adults with heart failure
25. Nino Cmor, Eva Dora, Mitja Lainščak, Miha Tibaut: Polymicrobial purulent pericarditis and peritoneal effusion in an immunocompromised patient with Staphylococcus aureus bacteraemia
26. Gianluigi Savarese, Felix Lindberg, Antonio Cannata, Ovidiu Chioncel, Davide Stolfo, Francesca Musella, Daniela Tomasoni, Magdy Abdelhamid, Debasish Banerjee, Antoni Bayes-Genis, Mitja Lainščak: How to tackle therapeutic inertia in heart failure with reduced ejection fraction